Prednizolon Садржај Osobine Reference Literatura Spoljašnje veze Мени за навигацијуMonografija50-24-8WHOAB0757552866DB008605552C07369CHEBI:8378CHEMBL131„DrugBank 3.0: a comprehensive resource for omics research on drugs”30137092105968210.1093/nar/gkq1126„DrugBank: a knowledgebase for drugs, drug actions and drug targets”22388891804841210.1093/nar/gkm958„Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”10.1021/jp980230o„Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”1174957310.1021/ci000392t„Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”1102028610.1021/jm000942eGoodman & Gilman's The Pharmacological Basis of Therapeutics10.1036/0071422803Foye's Principles of Medicinal ChemistryPrednizolonVikimedijinoj ostaviPrednisoloneу
Хемотерапијски агенсиАнтиинфламаторни агенсиХормонски агенсиГлукокортикоидиАлкохолиСтероидиКетониЉудски метаболити лекова
organsko jedinjenjeatomugljenikamolekulsku masuDaMENDanatphysdevphormcellnocodcongtumrsysieponproclekA10H1H2H3H5
(function()var node=document.getElementById("mw-dismissablenotice-anonplace");if(node)node.outerHTML="u003Cdiv class="mw-dismissable-notice"u003Eu003Cdiv class="mw-dismissable-notice-close"u003E[u003Ca tabindex="0" role="button"u003Eсакријu003C/au003E]u003C/divu003Eu003Cdiv class="mw-dismissable-notice-body"u003Eu003Cdiv id="localNotice" lang="sr" dir="ltr"u003Eu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.25em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003Eu003Cuu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%90%D0%BA%D1%86%D0%B8%D1%98%D0%B0_%D1%80%D0%B5%D1%84%D0%B5%D1%80%D0%B5%D0%BD%D1%86%D0%B8%D1%80%D0%B0%D1%9A%D0%B0_%D1%87%D0%BB%D0%B0%D0%BD%D0%B0%D0%BA%D0%B0" title="Википедија:Акција референцирања чланака"u003Eu003Cspan style="color:white"u003EУчествујте у Акцији референцирања чланака од 18. до 31. јула.u003C/spanu003Eu003C/au003Eu003C/uu003Eu003C/divu003Enu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.25em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003EУ току је гласање о давању администраторских права корисницима u003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%97%D0%B0%D1%85%D1%82%D0%B5%D0%B2%D0%B8_%D0%B7%D0%B0_%D0%B0%D0%B4%D0%BC%D0%B8%D0%BD%D0%B8%D1%81%D1%82%D1%80%D0%B8%D1%80%D0%B0%D1%9A%D0%B5/%D0%94%D0%B0%D0%B2%D0%B0%D1%9A%D0%B5/Acamicamacaraca" title="Википедија:Захтеви за администрирање/Давање/Acamicamacaraca"u003Eu003Cspan style="color:white"u003Eu003Cuu003EAcamicamacaracau003C/uu003Eu003C/spanu003Eu003C/au003E, u003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%97%D0%B0%D1%85%D1%82%D0%B5%D0%B2%D0%B8_%D0%B7%D0%B0_%D0%B0%D0%B4%D0%BC%D0%B8%D0%BD%D0%B8%D1%81%D1%82%D1%80%D0%B8%D1%80%D0%B0%D1%9A%D0%B5/%D0%94%D0%B0%D0%B2%D0%B0%D1%9A%D0%B5/MarinaSimic" title="Википедија:Захтеви за администрирање/Давање/MarinaSimic"u003Eu003Cspan style="color:white"u003Eu003Cuu003EMarinaSimicu003C/uu003Eu003C/spanu003Eu003C/au003E и u003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%97%D0%B0%D1%85%D1%82%D0%B5%D0%B2%D0%B8_%D0%B7%D0%B0_%D0%B0%D0%B4%D0%BC%D0%B8%D0%BD%D0%B8%D1%81%D1%82%D1%80%D0%B8%D1%80%D0%B0%D1%9A%D0%B5/%D0%94%D0%B0%D0%B2%D0%B0%D1%9A%D0%B5/VS6507_2" title="Википедија:Захтеви за администрирање/Давање/VS6507 2"u003Eu003Cspan style="color:white"u003Eu003Cuu003EVS6507u003C/uu003Eu003C/spanu003Eu003C/au003E.u003C/divu003Enu003Cdiv style="position:relative; overflow:hidden; background-color:#5E9DC8; text-align:center; color:white; font-size:1.25em; font-weight:bold; line-height:1.5em; margin-top: 5px;"u003EУ току је гласање о давању бирократског права кориснику u003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%97%D0%B0%D1%85%D1%82%D0%B5%D0%B2%D0%B8_%D0%B7%D0%B0_%D0%B0%D0%B4%D0%BC%D0%B8%D0%BD%D0%B8%D1%81%D1%82%D1%80%D0%B8%D1%80%D0%B0%D1%9A%D0%B5/%D0%91%D0%B8%D1%80%D0%BE%D0%BA%D1%80%D0%B0%D1%82%D0%B0/Zoranzoki21" title="Википедија:Захтеви за администрирање/Бирократа/Zoranzoki21"u003Eu003Cspan style="color:white"u003Eu003Cuu003EZoranzoki21u003C/uu003Eu003C/spanu003Eu003C/au003E.u003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003E";());
Prednizolon
Иди на навигацију
Иди на претрагу
 | |
 | |
| Klinički podaci | |
|---|---|
| Prodajno ime | Ak-Pred, Ak-Tate, Alphadrol, Articulose-50 |
| Drugs.com | Monografija |
| Način primene | Oralno, oftalmički |
Farmakokinetički podaci | |
| Poluvreme eliminacije | 2-3 h |
| Identifikatori | |
| CAS broj | 50-24-8  Y |
| ATC kod | A07EA01 (WHO), H02AB07 |
| PubChem | CID 5755 |
| IUPHAR/BPS | 2866 |
| DrugBank | DB00860 Y |
| ChemSpider | 5552 Y |
| KEGG | C07369 Y |
| ChEBI | CHEBI:8378 Y |
| ChEMBL | CHEMBL131 Y |
| Hemijski podaci | |
| Formula | C21H28O5 |
| Molarna masa | 360,444 |
SMILES
| |
InChI
| |
| Fizički podaci | |
| Tačka topljenja | 235 °C (455 °F) |
Prednizolon je organsko jedinjenje, koje sadrži 21 atom ugljenika i ima molekulsku masu od 360,444 Da.[1][2]
Садржај
1 Osobine
2 Reference
3 Literatura
4 Spoljašnje veze
Osobine
| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 5 |
| Broj donora vodonika | 3 |
| Broj rotacionih veza | 2 |
Particioni koeficijent[3] (ALogP) | 1,3 |
Rastvorljivost[4] (logS, log(mol/L)) | -3,3 |
Polarna površina[5] (PSA, Å2) | 94,8 |
Reference
^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889. PMID 18048412. doi:10.1093/nar/gkm958.
^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
.mw-parser-output .refbeginfont-size:90%;margin-bottom:0.5em.mw-parser-output .refbegin-hanging-indents>ullist-style-type:none;margin-left:0.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>ddmargin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none.mw-parser-output .refbegin-100font-size:100%
Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
 | Prednizolon na Vikimedijinoj ostavi. |
- Prednisolone
 | Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |
Категорије:
- Хемотерапијски агенси
- Антиинфламаторни агенси
- Хормонски агенси
- Глукокортикоиди
- Алкохоли
- Стероиди
- Кетони
- Људски метаболити лекова
(RLQ=window.RLQ||[]).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.784","walltime":"1.096","ppvisitednodes":"value":4256,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":145081,"limit":2097152,"templateargumentsize":"value":7169,"limit":2097152,"expansiondepth":"value":17,"limit":40,"expensivefunctioncount":"value":0,"limit":500,"unstrip-depth":"value":0,"limit":20,"unstrip-size":"value":10128,"limit":5000000,"entityaccesscount":"value":1,"limit":400,"timingprofile":["100.00% 968.233 1 -total"," 36.63% 354.691 4 Шаблон:Infobox"," 35.53% 343.978 1 Шаблон:Drugbox-lat"," 30.79% 298.152 1 Шаблон:Commonscat-lat"," 17.08% 165.408 1 Шаблон:Reflist"," 12.84% 124.361 4 Шаблон:Cite_pmid"," 12.81% 124.026 5 Шаблон:Cite_journal"," 6.33% 61.307 1 Шаблон:Cite_pmid/21059682"," 6.13% 59.397 2 Шаблон:Navbox"," 5.95% 57.640 1 Шаблон:Kortikosteroidi-lat"],"scribunto":"limitreport-timeusage":"value":"0.345","limit":"10.000","limitreport-memusage":"value":7132612,"limit":52428800,"cachereport":"origin":"mw1270","timestamp":"20190625101319","ttl":2592000,"transientcontent":false););"@context":"https://schema.org","@type":"Article","name":"Prednizolon","url":"https://sr.wikipedia.org/wiki/Prednizolon","sameAs":"http://www.wikidata.org/entity/Q11426176","mainEntity":"http://www.wikidata.org/entity/Q11426176","author":"@type":"Organization","name":"u0421u0430u0440u0430u0434u043du0438u0446u0438 u043fu0440u043eu0458u0435u043au0430u0442u0430 u0412u0438u043au0438u043cu0435u0434u0438u0458u0435","publisher":"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":"@type":"ImageObject","url":"https://www.wikimedia.org/static/images/wmf-hor-googpub.png","datePublished":"2013-12-20T02:59:25Z","dateModified":"2017-01-04T07:00:12Z","image":"https://upload.wikimedia.org/wikipedia/commons/0/05/Prednisolone-2D-skeletal.svg"(RLQ=window.RLQ||[]).push(function()mw.config.set("wgBackendResponseTime":137,"wgHostname":"mw1254"););
